Dendritic Cells Therapy with Cytokine-Induced Killer Cells and Activated Cytotoxic T Cells Attenuated Th2 Bias Immune Response
Author:
Affiliation:
1. Qingdao Central Hospital, The Second Clinical Hospital of Qingdao University, Qingdao, China
2. Cancer Biotherapy Center of Qingdao Key Lab, Qingdao, China
3. Queen Mary School, Medical college of Nanchang University, Nanchang, China
Funder
National Natural Science Foundation of China
Applied Basic Research Program of Qingdao
Publisher
Informa UK Limited
Subject
General Medicine,Immunology
Link
https://www.tandfonline.com/doi/pdf/10.1080/08820139.2019.1696360
Reference34 articles.
1. Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
2. Clinical peptide vaccination trials for leukemia patients
3. Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma
4. Preconditioning Chemotherapy with Cisplatin Enhances the Antitumor Activity of Cytokine-Induced Killer Cells in a Murine Melanoma Model
5. PD-1+ Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. MMP9-Associated Tumor Stem Cells, CCL1-Silenced Dendritic Cells, and Cytokine-Induced Killer Cells Have a Remarkable Therapeutic Efficacy for Acute Myeloid Leukemia by Activating T Cells;Stem Cells International;2023-05-09
2. Microneedle-based two-step transdermal delivery of Langerhans cell-targeting immunoliposomes induces a Th1-biased immune response;European Journal of Pharmaceutics and Biopharmaceutics;2022-08
3. A weighted fuzzy C-means clustering method for hardness prediction;Journal of Iron and Steel Research International;2022-05-18
4. Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer;Frontiers in Immunology;2021-08-02
5. SARS-CoV-2: Unique Challenges of the Virus and Vaccines;Immunological Investigations;2021-06-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3